Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

Mei Zhao,Tianxiao Wang,Frederico O. Gleber-Netto,Zhen Chen,Daniel J. McGrail,Javier A. Gomez,Wutong Ju,Mayur A. Gadhikar,Wencai Ma,Li Shen,Qi Wang,Ximing Tang,Sen Pathak,Maria Gabriela Raso,Jared K. Burks,Shiaw-Yih Lin,Jing Wang,Asha S. Multani,Curtis R. Pickering,Junjie Chen,Jeffrey N. Myers,Ge Zhou

DOI: https://doi.org/10.1038/s41467-023-44239-2

IF: 16.6

2024-01-02

Nature Communications

Abstract:Abstract Inactivating TP53 mutations leads to a loss of function of p53, but can also often result in oncogenic gain-of-function (GOF) of mutant p53 (mutp53) proteins which promotes tumor development and progression. The GOF activities of TP53 mutations are well documented, but the mechanisms involved remain poorly understood. Here, we study the mutp53 interactome and find that by targeting minichromosome maintenance complex components (MCMs), GOF mutp53 predisposes cells to replication stress and chromosomal instability (CIN), leading to a tumor cell-autonomous and cyclic GMP–AMP synthase (cGAS)-stimulator of interferon genes (STING)-dependent cytosolic DNA response that activates downstream non-canonical nuclear factor kappa light chain enhancer of activated B cell (NC-NF-κB) signaling. Consequently, GOF mutp53-MCMs-CIN-cytosolic DNA-cGAS-STING-NC-NF-κB signaling promotes tumor cell metastasis and an immunosuppressive tumor microenvironment through antagonizing interferon signaling and regulating genes associated with pro-tumorigenic inflammation. Our findings have important implications for understanding not only the GOF activities of TP53 mutations but also the genome-guardian role of p53 and its inactivation during tumor development and progression.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper primarily explores how mutant p53 (mutp53) interacts with the minichromosome maintenance complex (MCM), leading to replication stress and chromosomal instability (CIN), which in turn activates the cytosolic DNA response and promotes tumor progression and an immunosuppressive tumor microenvironment. Specifically: 1. **Interaction between mutant p53 and MCMs**: The study found that mutant p53 can interact with MCM5 and MCM7 within the MCMs, and this interaction may affect the regulation of DNA replication. 2. **Replication stress and chromosomal instability**: Mutant p53, through its interaction with MCM5, makes cells more susceptible to replication stress, leading to increased chromosomal instability. 3. **Cytosolic DNA response**: Due to replication stress and chromosomal instability, genomic DNA enters the cytosol, activating the cGAS-STING pathway, which results in atypical NF-κB signaling. 4. **Tumor metastasis and immunosuppression**: This atypical NF-κB signaling further promotes tumor cell metastasis and creates an immunosuppressive microenvironment that favors tumor growth. In summary, this paper aims to reveal how mutant p53, through its interaction with MCMs, leads to chromosomal instability, activates the cytosolic DNA response, and ultimately promotes tumor development and metastasis. These findings are significant for understanding the gain-of-function (GOF) of TP53 mutations and the role of p53 in tumor progression.

Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA response

Inhibition of nonsense-mediated decay rescues p53/ isoform expression and activates the p53 pathway in and select-mutant cancers

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Gain-of-function mutant p53 in cancer progression and therapy

Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway

Mutant p53 suppresses innate immune signaling to promote tumorigenesis

Mutant P53 Gains Its Function Via C-Myc Activation Upon CDK4 Phosphorylation at Serine 249 and Consequent PIN1 Binding

Differential Gain-of-Function Activity of Three P53 Hotspot Mutants in Vivo

Modeling the Etiology of p53-mutated Cancer Cells

Mutant p53 in Cancer Progression and Targeted Therapies

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Differences in gainof-function and inhibitory effects amongst p53 mutants in vivo

Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical Chemotherapy

Mutant p53 in cancer therapy-the barrier or the path.

Mutant P53 in Cancer: Accumulation, Gain-of-Function, and Therapy.

P53 Gain-of-function Cancer Mutants Induce Genetic Instability by Inactivating ATM

Gain-of-function Mutant P53 Activates Small GTPase Rac1 Through SUMOylation to Promote Tumor Progression

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

Abstract A042: Differences in Gain-of-function and Inhibitory Effects Amongst P53 Mutants in Vivo

Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe

Mutant p53 as a guardian of the cancer cell